US equity
·Updated Oct 12, 21:38 UTCVERI
Veritone, Inc.
Technology·Small cap·$56M
0.6059
+9.6% today
No price history available for this name yet.
Returns & momentum
1D+9.6%
1W-16.5%
1M-41.7%
3M-43.4%
6M-70.2%
1Y-88.5%
YTD—
All-time—
Range & moving averages
Price0.6059
52w high-93.6%
52w low+14.1%
All-time high—
All-time low—
% from ATH—
50-day MA—
vs 50-DMA—
200-day MA—
vs 200-DMA—
Liquidity & activity
Volume7.8M
Turnover$5M
Market cap$56M
RVOL1.33×
Risk & valuation
Real. vol 30d—
Real. vol 90d—
Max drawdown—
Beta · SPY—
P/E—
P/B—
ROE—
Div yield—
Financials
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $92M | $93M | $100M | $150M | $115M | $58M | $50M | $27M | $14M | $9M |
| Cost of revenue | — | — | $28M | $27M | $22M | $16M | $15M | $6M | $1M | $2M |
| Gross profit | — | — | — | — | — | — | $32M | $21M | $13M | $7M |
| Research & development | $21M | $27M | $41M | $44M | $25M | $14M | $23M | $22M | $14M | $8M |
| Operating expenses | — | — | — | — | — | — | $96M | $83M | $60M | $31M |
| Operating income | -$81M | -$88M | -$100M | -$38M | -$61M | -$48M | -$64M | -$62M | -$47M | -$24M |
| Interest expense | — | — | — | — | — | — | — | — | $4M | $4M |
| Income tax | -$228K | -$4M | -$3M | $2M | $3M | $76K | -$1M | $22K | $6K | $6K |
| Net income | — | — | — | -$26M | $65M | -$48M | -$62M | -$61M | -$60M | -$27M |
| EPS — basic | -$1.76 | -$0.98 | -$1.59 | -$0.71 | -$1.94 | — | — | — | — | — |
| EPS — diluted | -$1.76 | -$0.98 | -$1.59 | -$0.71 | -$1.94 | — | — | — | — | — |
| Shares — basic | 63.32M | 38.04M | 36.91M | 36.03M | 33.31M | 27.61M | 21.85M | 17.68M | 10.52M | 2.21M |
| Shares — diluted | 63.32M | 38.04M | 36.91M | 36.03M | — | — | — | — | — | — |
From SEC filings (public domain), since 2016. Values as reported (USD); per-share figures are per diluted/basic share. Point-in-time — each figure reflects the latest amount filed for that period. Descriptive context only, not advice.
Informational scan, not a buy/sell recommendation or financial advice in any jurisdiction.